AC
CRL icon

Allstate Corporation’s Charles River Laboratories CRL Stock Holding History

Allstate Corporation’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
5,958
+665
+13% +$118K 0.01% 632
2026
Q1 		$913K Buy
+5,293
New +$981K 0.01% 844
2025
Q1 		– Sell
-1,500
Closed -$277K – 596
2024
Q4 		$277K Buy
+1,500
New +$289K 0.01% 595
2023
Q1 		– Sell
-1,246
Closed -$272K – 284
2022
Q4 		$272K Buy
+1,246
New +$272K 0.01% 557
2022
Q2 		– Sell
-3,246
Closed -$922K – 603
2022
Q1 		$922K Buy
+3,246
New +$1M 0.02% 412

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Allstate Corporation's CRL Position: Q2 2026 in Review

Allstate Corporation increased its Charles River Laboratories (CRL) stake by 13% in Q2 2026, buying an estimated $118K and bringing the position to 5,958 shares worth $1.35M. The position accounts for 0.01% of the portfolio, ranked #632.

Allstate Corporation first reported a position in CRL in Q1 2022 and has held it in 5 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Allstate Corporation held 5,958 shares of Charles River Laboratories worth $1.35M as of Q2 2026.
  • Allstate Corporation bought 665 Charles River Laboratories shares in Q2 2026, an estimated $118K.
  • Charles River Laboratories made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #632 holding.
  • Allstate Corporation first reported a position in Charles River Laboratories in Q1 2022 and has held it in 5 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.